RxDoctor Payments Data

Elizabeth Scherrey, APRN

Women's Health · Fort Smith, ARNPI 1801436886

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $358 and has fallen 84.8% since, to $54 in 2025.

$1,107in general payments, 2019–2025

Across 63 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$247
  • Mayne Pharma Commercial LLC$193
  • Exeltis, USA Inc.$118
  • Lilly USA, LLC$98
  • Organon$63
  • Sumitomo Pharma America, Inc.$61
  • plus $328 from 11 others

What the payments were for

  • Food & beverage$1,107100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,107 in reported general payments places this provider in the 70th percentile of 44 women's health providers in Arkansas.

See all women's health providers in Arkansas

Medicare billing

Part B allowed, 2024
$1,795
Medicare patients
23
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol74$2,994
ValacyclovirValacyclovir Hcl11$986

Paid to pharmacies, not to this prescriber.

Other women's health in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →